Anthropic launches drug discovery programs for neglected diseases
Anthropic launches drug discovery programs targeting diseases deemed unprofitable by the pharmaceutical industry.
Published 1sem1 sourceNotable
Lire en français
≈ 24s
16 %
Novartis CEO suggests AI could cut drug development timelines from 12 to 7-8 years and doubl…
The fact
Novartis CEO suggests AI could cut drug development timelines from 12 to 7-8 years and double success rates (8% to 16%).
The initiative aims to address gaps left by traditional labs, which often avoid investing in these conditions.
Click the link to read an article on the topic: